SOLID ADVANCED TUMOR
Clinical trials for SOLID ADVANCED TUMOR explained in plain language.
Never miss a new study
Get alerted when new SOLID ADVANCED TUMOR trials appear
Sign up with your email to follow new studies for SOLID ADVANCED TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New cancer drug combo shows promise in early trials
Disease control Recruiting nowThis early-stage study is testing a new immunotherapy drug called OSE-279, both alone and in combination with another drug, for people with advanced solid tumors or lymphomas. The trial aims to find safe doses and see if these treatments can help control cancer growth. It's speci…
Matched conditions: SOLID ADVANCED TUMOR
Phase: PHASE1, PHASE2 • Sponsor: OSE Immunotherapeutics • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC
-
New Two-Pronged attack on tough cancers enters human testing
Disease control Recruiting nowThis study is testing a new combination of two drugs, MCLA-129 and ensartinib, for people with advanced solid tumors that have a specific genetic feature called MET. The first part of the study aims to find a safe and effective dose. The second part will see how well the combinat…
Matched conditions: SOLID ADVANCED TUMOR
Phase: PHASE1, PHASE2 • Sponsor: Betta Pharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Mar 11, 2026 14:53 UTC